Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Burkholderia vietnamiensis Elongation factor Ts (tsf) CSB-YP025124BPV
CSB-EP025124BPV
CSB-BP025124BPV
CSB-MP025124BPV
CSB-EP025124BPV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia vietnamiensis Protoheme IX farnesyltransferase (ctaB), partial CSB-YP005824BPV
CSB-EP005824BPV
CSB-BP005824BPV
CSB-MP005824BPV
CSB-EP005824BPV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia vietnamiensis Methionyl-tRNA formyltransferase (fmt) CSB-YP015150BPV
CSB-EP015150BPV
CSB-BP015150BPV
CSB-MP015150BPV
CSB-EP015150BPV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia vietnamiensis Argininosuccinate synthase (argG) CSB-YP002234BPV
CSB-EP002234BPV
CSB-BP002234BPV
CSB-MP002234BPV
CSB-EP002234BPV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Papio anubis WAP four-disulfide core domain protein 5 (WFDC5) CSB-YP026094ERI
CSB-EP026094ERI
CSB-BP026094ERI
CSB-MP026094ERI
CSB-EP026094ERI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pan troglodytes Potassium voltage-gated channel subfamily S member 1 (KCNS1), partial CSB-YP012095EQV1
CSB-EP012095EQV1
CSB-BP012095EQV1
CSB-MP012095EQV1
CSB-EP012095EQV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Colobus guereza Potassium voltage-gated channel subfamily S member 1 (KCNS1), partial CSB-YP012095DVH1
CSB-EP012095DVH1
CSB-BP012095DVH1
CSB-MP012095DVH1
CSB-EP012095DVH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Otolemur garnettii Serine/threonine-protein kinase 4 (STK4) CSB-YP022855OFS
CSB-EP022855OFS
CSB-BP022855OFS
CSB-MP022855OFS
CSB-EP022855OFS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Otolemur garnettii WAP four-disulfide core domain protein 5 (WFDC5) CSB-YP026094OFS
CSB-EP026094OFS
CSB-BP026094OFS
CSB-MP026094OFS
CSB-EP026094OFS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lemur catta Serine/threonine-protein kinase 4 (STK4) CSB-YP022855LOK
CSB-EP022855LOK
CSB-BP022855LOK
CSB-MP022855LOK
CSB-EP022855LOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii Potassium voltage-gated channel subfamily S member 1 (KCNS1), partial CSB-YP012095PYX1
CSB-EP012095PYX1
CSB-BP012095PYX1
CSB-MP012095PYX1
CSB-EP012095PYX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii Protein SYS1 homolog (SYS1), partial CSB-YP023027PYX1
CSB-EP023027PYX1
CSB-BP023027PYX1
CSB-MP023027PYX1
CSB-EP023027PYX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aotus nancymaae WAP four-disulfide core domain protein 5 (WFDC5) CSB-YP026094AUV
CSB-EP026094AUV
CSB-BP026094AUV
CSB-MP026094AUV
CSB-EP026094AUV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saimiri boliviensis boliviensis WAP four-disulfide core domain protein 12 (WFDC12) CSB-YP026090SWC
CSB-EP026090SWC
CSB-BP026090SWC
CSB-MP026090SWC
CSB-EP026090SWC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorocebus aethiops WAP four-disulfide core domain protein 5 (WFDC5) CSB-YP026094DSU
CSB-EP026094DSU
CSB-BP026094DSU
CSB-MP026094DSU
CSB-EP026094DSU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eulemur macaco DNA nucleotidylexotransferase (DNTT), partial CSB-YP007088EJG
CSB-EP007088EJG
CSB-BP007088EJG
CSB-MP007088EJG
CSB-EP007088EJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Elizabethkingia meningoseptica Alpha-N-acetylgalactosaminidase (nagA) CSB-YP015414FEW
CSB-EP015414FEW
CSB-BP015414FEW
CSB-MP015414FEW
CSB-EP015414FEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Porphobilinogen deaminase (hemC) CSB-YP010524CXG
CSB-EP010524CXG
CSB-BP010524CXG
CSB-MP010524CXG
CSB-EP010524CXG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum Elongation factor G (fusA), partial CSB-YP009373CXG
CSB-EP009373CXG
CSB-BP009373CXG
CSB-MP009373CXG
CSB-EP009373CXG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium glutamicum ATP synthase subunit delta (atpH) CSB-YP002355CXG
CSB-EP002355CXG
CSB-BP002355CXG
CSB-MP002355CXG
CSB-EP002355CXG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>